Welcome to ACR Biologics
Our Focus: Non-Healing Chronic Wounds
Our Goal: To utilize our unique Autologous Cellular-Rich Biologic products, patient- specific procedures and trained medical staff to optimize wound healing in various stages of chronic non-healing wounds.
Applied Clinical Research: Advances in molecular science have allowed modern medicine to better understand the complex sequencing and intercellular signaling that occur within our body when we receive an injury. While specific processes have not been fully differentiated, a better understanding does allow the practitioner to counsel a patient and more effectively treat an injury or non-healing wound.
Accelerated Clinical Results: At ACR Biologics our products and procedures optimize the conditions that allow a wound to quickly heal. Wound healing is a complex and dynamic process of replacing devitalized and missing cellular structures and layers of tissue. Our product mix is designed to work within each phase of the healing process to rebuild these structures. We start with products that are non-cytotoxic killing organisms but not tissue. The next step is to help the body rebuild and regenerate missing tissue. Finally we assist in allowing this tissue to mature, remodel and regain lost tensile strength.
At ACR Biologics, our outcomes are a testament that PlasmaDerm and the Sequence product line have the ability to be a front-line standard of care when healing chronic wounds. Our commitment is providing results-based medicine, cost containment and in restoring quality of life to our patients.
Our Focus: Non-Healing Chronic Wounds
Our Goal: To utilize our unique Autologous Cellular-Rich Biologic products, patient- specific procedures and trained medical staff to optimize wound healing in various stages of chronic non-healing wounds.
Applied Clinical Research: Advances in molecular science have allowed modern medicine to better understand the complex sequencing and intercellular signaling that occur within our body when we receive an injury. While specific processes have not been fully differentiated, a better understanding does allow the practitioner to counsel a patient and more effectively treat an injury or non-healing wound.
Accelerated Clinical Results: At ACR Biologics our products and procedures optimize the conditions that allow a wound to quickly heal. Wound healing is a complex and dynamic process of replacing devitalized and missing cellular structures and layers of tissue. Our product mix is designed to work within each phase of the healing process to rebuild these structures. We start with products that are non-cytotoxic killing organisms but not tissue. The next step is to help the body rebuild and regenerate missing tissue. Finally we assist in allowing this tissue to mature, remodel and regain lost tensile strength.
At ACR Biologics, our outcomes are a testament that PlasmaDerm and the Sequence product line have the ability to be a front-line standard of care when healing chronic wounds. Our commitment is providing results-based medicine, cost containment and in restoring quality of life to our patients.
Management
Charles Worden Jr., Vice President
Charles Worden Jr. joined ACR Biologics in August of 2013 and has more than 20 years of experience in the regenerative medicine industry. Prior to joining ACR Biologics, Mr. Worden was a founding member and Vice President of SafeBlood Technologies developing PRP therapy models specifically for LTACH, ASC and Outpatient wound care. It is Mr. Worden’s belief that our outcomes are a testament that PlasmaDerm and the Sequence product line have the ability to be a front-line standard of care when healing chronic wounds. Our commitment is providing results-based medicine, cost containment and in restoring quality of life to our patients.
Thank you for your interest in ACR Biologics. For further information and assistance, please contact us.
